|
Volumn 2012, Issue , 2012, Pages 43-48
|
The prevalent predicament of relapsed acute myeloid leukemia.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENINE NUCLEOTIDE;
AMINOGLYCOSIDE;
ARABINONUCLEOSIDE;
CD135 ANTIGEN;
CLOFARABINE;
DRUG DERIVATIVE;
FLT3 PROTEIN, HUMAN;
GEMTUZUMAB;
GLYCINE;
HYDROXAMIC ACID;
MONOCLONAL ANTIBODY;
MTOR PROTEIN, HUMAN;
TARGET OF RAPAMYCIN KINASE;
TOSEDOSTAT;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
AGED;
ALLOTRANSPLANTATION;
CLINICAL TRIAL (TOPIC);
DECISION MAKING;
DNA METHYLATION;
DRUG ANTAGONISM;
HUMAN;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
PATHOLOGY;
PROGNOSIS;
RECURRENT DISEASE;
REMISSION;
REVIEW;
RISK FACTOR;
SALVAGE THERAPY;
STEM CELL TRANSPLANTATION;
ADENINE NUCLEOTIDES;
ADULT;
AGED;
AMINOGLYCOSIDES;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ARABINONUCLEOSIDES;
CLINICAL TRIALS AS TOPIC;
DECISION MAKING;
DNA METHYLATION;
FMS-LIKE TYROSINE KINASE 3;
GLYCINE;
HUMANS;
HYDROXAMIC ACIDS;
LEUKEMIA, MYELOID, ACUTE;
MIDDLE AGED;
PROGNOSIS;
RECURRENCE;
REMISSION INDUCTION;
RISK FACTORS;
SALVAGE THERAPY;
STEM CELL TRANSPLANTATION;
TOR SERINE-THREONINE KINASES;
TRANSPLANTATION, HOMOLOGOUS;
MLCS;
MLOWN;
|
EID: 84879377399
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation.v2012.1.43.3798183 Document Type: Review |
Times cited : (38)
|
References (0)
|